Effects of tall man lettering on the visual behaviour of critical care nurses while identifying syringe drug labels: a randomised in situ simulation.


Journal

BMJ quality & safety
ISSN: 2044-5423
Titre abrégé: BMJ Qual Saf
Pays: England
ID NLM: 101546984

Informations de publication

Date de publication:
01 2023
Historique:
received: 03 11 2021
accepted: 11 02 2022
pubmed: 10 3 2022
medline: 27 12 2022
entrez: 9 3 2022
Statut: ppublish

Résumé

Patients in intensive care units are prone to the occurrence of medication errors. Look-alike, sound-alike drugs with similar drug names can lead to medication errors and therefore endanger patient safety. Capitalisation of distinct text parts in drug names might facilitate differentiation of medication labels. The aim of this study was to test whether the use of such 'tall man' lettering (TML) reduces the error rate and to examine effects on the visual attention of critical care nurses while identifying syringe labels. This was a prospective, randomised in situ simulation conducted at the University Hospital Zurich, Zurich, Switzerland. Under observation by eye tracking, 30 nurses were given 10 successive tasks involving the presentation of a drug name and its selection from a dedicated set of 10 labelled syringes that included look-alike and sound-alike drug names, half of which had TML-coded labels.Error rate as well as dwell time, fixation count, fixation duration and revisits were analysed using a linear mixed-effects model analysis to compare TML-coded with non-TML-coded labels. TML coding of syringe labels led to a significant decrease in the error rate (from 5.3% (8 of 150 in non-TML-coded sets) to 0.7% (1 of 150 in TML-coded sets), p<0.05). Eye tracking further showed that TML affects visual attention, resulting in longer dwell time (p<0.01), more and longer fixations (p<0.05 and p<0.01, respectively) on the drug name as well as more frequent revisits (p<0.01) compared with non-TML-coded labels. Detailed analysis revealed that these effects were stronger for labels using TML in the mid-to-end position of the drug name. TML in drug names changes visual attention while identifying syringe labels and supports critical care nurses in preventing medication errors.

Sections du résumé

BACKGROUND
Patients in intensive care units are prone to the occurrence of medication errors. Look-alike, sound-alike drugs with similar drug names can lead to medication errors and therefore endanger patient safety. Capitalisation of distinct text parts in drug names might facilitate differentiation of medication labels. The aim of this study was to test whether the use of such 'tall man' lettering (TML) reduces the error rate and to examine effects on the visual attention of critical care nurses while identifying syringe labels.
METHODS
This was a prospective, randomised in situ simulation conducted at the University Hospital Zurich, Zurich, Switzerland. Under observation by eye tracking, 30 nurses were given 10 successive tasks involving the presentation of a drug name and its selection from a dedicated set of 10 labelled syringes that included look-alike and sound-alike drug names, half of which had TML-coded labels.Error rate as well as dwell time, fixation count, fixation duration and revisits were analysed using a linear mixed-effects model analysis to compare TML-coded with non-TML-coded labels.
RESULTS
TML coding of syringe labels led to a significant decrease in the error rate (from 5.3% (8 of 150 in non-TML-coded sets) to 0.7% (1 of 150 in TML-coded sets), p<0.05). Eye tracking further showed that TML affects visual attention, resulting in longer dwell time (p<0.01), more and longer fixations (p<0.05 and p<0.01, respectively) on the drug name as well as more frequent revisits (p<0.01) compared with non-TML-coded labels. Detailed analysis revealed that these effects were stronger for labels using TML in the mid-to-end position of the drug name.
CONCLUSIONS
TML in drug names changes visual attention while identifying syringe labels and supports critical care nurses in preventing medication errors.

Identifiants

pubmed: 35260415
pii: bmjqs-2021-014438
doi: 10.1136/bmjqs-2021-014438
pmc: PMC9811086
doi:

Types de publication

Journal Article

Langues

eng

Pagination

26-33

Commentaires et corrections

Type : CommentIn

Informations de copyright

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Minerva Anestesiol. 2020 Nov;86(11):1180-1189
pubmed: 32643360
BMJ Qual Saf. 2016 Apr;25(4):233-40
pubmed: 26534995
J Med Syst. 2019 Dec 6;44(1):12
pubmed: 31807889
Soc Sci Med. 2004 Dec;59(12):2597-601
pubmed: 15474212
Adv Health Sci Educ Theory Pract. 2015 Oct;20(4):1089-106
pubmed: 25677013
Resuscitation. 2020 Aug;153:176-182
pubmed: 32580005
Crit Care Med. 2005 Aug;33(8):1694-700
pubmed: 16096443
Arch Dis Child Fetal Neonatal Ed. 2018 Jan;103(1):F82-F84
pubmed: 28824007
BMJ Qual Saf. 2021 Feb;30(2):96-105
pubmed: 32527980
Health Informatics J. 2016 Sep;22(3):744-57
pubmed: 26142432
Calif Med. 1973 Nov;119(5):62
pubmed: 18731040
Br J Anaesth. 2011 Jan;106(1):44-50
pubmed: 21037266
Can J Anaesth. 2001 Feb;48(2):139-46
pubmed: 11220422
Br J Anaesth. 2011 Jun;106(6):807-13
pubmed: 21474477
Stud Health Technol Inform. 2016;228:604-8
pubmed: 27577455
Drug Saf. 2014 May;37(5):351-9
pubmed: 24718712
J Patient Saf. 2021 Dec 1;17(8):e1494-e1506
pubmed: 32251242
Pediatr Res. 2020 Feb;87(3):518-522
pubmed: 31499516
Appl Ergon. 2016 Jan;52:77-84
pubmed: 26360197
J Patient Saf. 2013 Sep;9(3):122-8
pubmed: 23860193
Eur J Clin Pharmacol. 2018 Aug;74(8):985-993
pubmed: 29754215
J Clin Monit Comput. 2021 Dec;35(6):1511-1518
pubmed: 33296061
BMJ Qual Saf. 2016 Apr;25(4):213-7
pubmed: 26700541
BMJ. 2019 Jul 17;366:l4185
pubmed: 31315828

Auteurs

Quentin Lohmeyer (Q)

Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.

Cornel Schiess (C)

Department of Nursing and Allied Health Care Professions, University Hospital Zurich, Zurich, Switzerland.

Pedro David Wendel Garcia (PD)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.

Heidi Petry (H)

Department of Nursing and Allied Health Care Professions, University Hospital Zurich, Zurich, Switzerland.

Eric Strauch (E)

Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.

Andreas Dietsche (A)

Department of Mechanical and Process Engineering, ETH Zurich, Zurich, Switzerland.

Reto A Schuepbach (RA)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.

Philipp K Buehler (PK)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland.

Daniel A Hofmaenner (DA)

Institute of Intensive Care Medicine, University Hospital Zurich, Zurich, Switzerland danielandrea.hofmaenner@usz.ch.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH